National Asset Management, Inc. Charles River Laboratories International, Inc. Transaction History

National Asset Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	BUY	$183.71 - $210.25 $275,013 - $314,744	1,497 Added 148.66%	2,504 $526,000
Q1 2023 May 17, 2023	SELL	$191.89 - $259.92 $112,831 - $152,832	-588 Reduced 36.87%	1,007 $203,000
Q4 2022 Feb 21, 2023	BUY	$197.11 - $250.07 $43,561 - $55,265	221 Added 16.08%	1,595 $347,000
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $18,608 - $25,555	102 Added 8.02%	1,374 $272,000
Q2 2022 Aug 12, 2022	BUY	$204.13 - $302.4 $66,138 - $97,977	324 Added 34.18%	1,272 $274,000
Q1 2022 May 02, 2022	BUY	$255.51 - $362.11 $242,223 - $343,280	948 New	948 $271,000

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on National Asset Management, Inc. with notifications on news.